WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'4101 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 14'6611 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 67'223  67'011  66'785  66'576  66'402  62'343  56'583  47'369 
Births 673  687  702  717  734  909  1'080  1'257 
Surviving infants 667  680  695  710  726  895  1'051  1'196 
Pop. less than 5 years 3'573  3'635  3'706  3'799  3'919  4'668  5'367  6'148 
Pop. less than 15 years 11'967  12'164  12'363  12'584  12'837  15'072  17'100  18'661 
Female 15-49 years 17'969  18'106  18'231  18'347  18'456  18'325  15'789  11'669 

Number of reported case

(Click for retrospective incidence data for Thailand)
Diphtheria 28  63  28  77  15  58  1'918 
Japanese encephalitis 59  54  52  40 
Measles 2'641  5'197  3'156  2'583  4'074  29'244  16'795 
Mumps 5'907  7'431  10'077  15'885  6'527 
Pertussis 24  14  12  93  487  4'820 
Polio* 20  300 
Rubella 539  493  517  387  1'136 
Rubella (CRS)
Tetanus (neonatal) 17  212  664 
Tetanus (total)** 126  105  110  126  220  813  1'818 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Thailand)
Vaccine year result method % card seen                                                
BCG 2011  98  MICS   82  99*  99*  99*  99*  99*  99  99*  68 
DTP1 2011  97  MICS   82  99*  99*  99*  99*  99*  99 
DTP3 2011  90  MICS   82  99  99  99  99  99  97  85  49 
DTP4          98 
IPV1         
HepB_BD          99*  99*  99*  99*  99*  99 
HepB3 2011  84  MICS   82  99  99  98  98  98  95 
Hib3         
JapEnc          92  92  95  95  95 
MCV1          99  99  98  98  98  94  70 
MCV2          94  94  91  91  91  99* 
PCV1         
PCV3         
Pol3 2011  91  MICS   82  99  99  99  99  99  97  89  19 
Rota1         
Rota_last         
Rubella1          99  99  98 
TT2plus 2011  71  MICS   82  98  98  97  97  97  90  76  28 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Thailand)
BCG 99  99  99  99  99  99  99  68 
DTP1 99  99  99  99  99  98  97  73 
DTP3 99  99  99  99  99  97  92  49 
HepB3 99  99  98  98  98  95 
HepB_BD 99  99  99  99  99  99 
Hib3
MCV1 99  99  98  98  98  94  80 
MCV2 94  94  91  91  91  99 
PAB 95  91  91  91  91  85  75  25 
PCV3
Pol3 99  99  99  99  99  97  92  19 
Rota_last

Number of districts in the country 928  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
CHOLERA No Travelller requirement in some countries
DTwP 1.5, 4 years; Yes
DTwPHep 2, 4, 6 months; Yes
HPV Girls grade 5, 6; No Pilot project in Pranakhonsri Ayuthaya Province
HepB birth; 1 month; Yes The dose at 1 month is especially give to newborn from HB carrier mother
Influenza 6 months - 2 years; >65 years; Yes Health care worker, elderly and chronic disease patient (COPD, asthma, CVS, chronic renal failure, Cancer patient during chemotherapy and DM)
JapEnc 1.5 (x2), 2.5 years; Yes Live attenuated vaccine pilot tested in 8 provinces (x2 doses)
MMR 9 months; 7 years; Yes school children grade 1
MR 9 months; 7 years; school children grade 1 (average age of 7 years old)
MenACWY No Traveler requirement in some countries
OPV 2, 4, 6 months; 1.5, 4 years; Yes
Rotavirus 2, 4 months; No in Sukhothai Province
Td Yes All school children in grade VI (average age of 12 years old) and Pregnant Women (no. of dose given depend on vaccine history if never : 1st contact +1 month, +6 months)
YF Yes Traveller to 32 countries in Africa and 13 countries in South America

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2016  2013-2016    2009-2012  2009-2012  2009-2012  2009-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 928  928  928         

System performance

Total Nº districts in country number 928  928  927  931  926  926  926 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100%
Nº districts with measles (MCV1) coverage >=95% number         NA  NA  NA 
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100      100  95  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.